Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of EUR 15.79 billion. The enterprise value is 15.88 billion.

Market Cap	15.79B
Enterprise Value	15.88B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	189.95M
Shares Outstanding	n/a
Shares Change (YoY)	+20.00%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	172.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.80
PB Ratio	172.16
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.94
EV / Sales	49.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.75

Financial Position

The company has a current ratio of 5.86, with a Debt / Equity ratio of 13.17.

Current Ratio	5.86
Quick Ratio	5.21
Debt / Equity	13.17
Debt / EBITDA	n/a
Debt / FCF	-1.65
Interest Coverage	-9.76

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-36.25%
Return on Invested Capital (ROIC)	-46.53%
Return on Capital Employed (ROCE)	-54.94%
Revenue Per Employee	277,363
Profits Per Employee	-737,586
Employee Count	1,271
Asset Turnover	0.26
Inventory Turnover	0.98

Taxes

In the past 12 months, Insmed has paid 3.73 million in taxes.

Income Tax	3.73M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.82%
50-Day Moving Average	69.70
200-Day Moving Average	68.86
Relative Strength Index (RSI)	56.81
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.08

Income Statement

In the last 12 months, Insmed had revenue of EUR 352.53 million and -937.47 million in losses. Loss per share was -5.45.

Revenue	352.53M
Gross Profit	269.67M
Operating Income	-794.75M
Pretax Income	-933.74M
Net Income	-937.47M
EBITDA	-786.27M
EBIT	-794.75M
Loss Per Share	-5.45

Full Income Statement

Balance Sheet

The company has 1.11 billion in cash and 1.21 billion in debt, giving a net cash position of -98.47 million.

Cash & Cash Equivalents	1.11B
Total Debt	1.21B
Net Cash	-98.47M
Net Cash Per Share	n/a
Equity (Book Value)	91.74M
Book Value Per Share	0.50
Working Capital	1.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -704.94 million and capital expenditures -25.27 million, giving a free cash flow of -730.21 million.

Operating Cash Flow	-704.94M
Capital Expenditures	-25.27M
Free Cash Flow	-730.21M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.49%, with operating and profit margins of -225.44% and -265.93%.

Gross Margin	76.49%
Operating Margin	-225.44%
Pretax Margin	-264.87%
Profit Margin	-265.93%
EBITDA Margin	-223.04%
EBIT Margin	-225.44%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.00%
Shareholder Yield	n/a
Earnings Yield	-5.94%
FCF Yield	-4.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of -0.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.23
Piotroski F-Score	3